PANACEA PHARMACEUTICALS ANNOUNCES APPOINTMENT

Panacea Pharmaceuticals, Inc. today announced the appointment of Stephen N. Keith, MD, MSPH as President and Chief Operating Officer. Dr. Keith will have responsibility for directing the company's therapeutic product development efforts for cancer and stroke, clinical development process for cancer diagnostics, as well as launching the cancer diagnostic laboratory services. American Venture Magazine (http://www.americanventuremagazine.com/news.php?newsid=1204)